Status
Conditions
Treatments
About
The objective of this study was to identify and build an algorithm through an imaging process using a support vector machine (SVM) with the tomography variables of cases with, KC, highly susceptible corneas to ectasia (HSCE), and healthy corneas and to compare this algorithm to BAD-D (Belin_Ambrosio Display) and PRFI (Pentacam Random Forest Index). The study included 148 eyes with KC, 351 with healthy corneas, and 88 eyes with HSCE.
Full description
Patients were considered to be very asymmetric (VAE-NT) if the diagnosis of ectasia was confirmed in one eye based on the previously described criteria and the fellow eye had a normal front surface curvature (topometric) map. Objective criteria for considering normal topography was applied for defining the cases of VAE-NT, including objective front surface curvature metrics derived from Pentacam. Normal topography was rigorously considered based on objective criteria of a maximum curvature Kmax (Steepest Front Keratometry) <47.2 diopters, a paracentral inferior-superior (I-S value) asymmetry value at 6 mm (3-mm radii) < 1.45, and keratoconus percentage index (KISA%) score < 60. The cutoff point used to discriminate normal corneas and VAE-NT from KC corneas was the maximal posterior elevation (< 29 micron. This cutoff point had been determined in a previous study, using the same instrument and the same setting (30). The posterior elevation map was displayed with a 5-mm color-coded scale, and maximal posterior elevation was measured manually using the cursor in the central 5 mm.
The study included 148 eyes with KC, 351 with healthy corneas, and 88 eyes with suspected KC. The patients were divided into three groups:
All subjects underwent complete eye examination as well as refraction assessment, biomicroscopy, retinoscopy, fundoscopy, topography, and tomography assessment. All patients were assessed at the Visum Eye Center between January 2012 and January 2018.
This study adhered to the tenets of the Declaration of Helsinki and was approved by the Research Ethics Committee of the Sao Jose do Rio Preto Faculty of Medicine. All patients were informed about the objectives of the study, and they signed written informed consent forms before being enrolled.
External validation was conducted with 140 patients, whose data were not included in building the algorithm. They met the same inclusion criteria as the others, with a total of 82 eyes of 82 patients with healthy corneas, 19 eyes of 19 patients with VAE-NT, and 39 eyes of 39 patients with KC.
PENTACAM TOMOGRAPHY: All eyes were examined by rotating Scheimpflug corneal and anterior segment tomography (Pentacam HR; Oculus GmbH, Wetzlar, Germany). Image quality was checked so that only cases with acceptable-quality images were included in the study. An experienced fellowship-trained corneal specialist (GCAJ) reviewed all the cases so that they were correctly classified in the KC and VAE-NT groups. The raw data (u12 files) were obtained from all cases; therefore, the same customized software (version 1.20r118) was used to process all the export files, and all Scheimpflug variables were directly downloaded from the Pentacam software using the "call-all" function.
MATHEMATICAL ALGORITHM: To build the equation extracted from SVM, 58 variables were used, some of them were extracted from the spreadsheet.. After the construction of these 58 feature vectors (FV), an SVM-derived index was created, which was called the corneal tomography multivariate index derived from a support vector machine (CTMVI). Considering that each patient represents a point on a cartesian plane with 58 dimensions (each coordinate representing one of the 58 FV), the role of SVM is to find the hyperplane that best separates the CG, KCG, and VAE-NT G subjects. A hyperplane is algebraically described by a linear equation; in this case, there are 59 coefficients, 58 of which are related to the FV and one independent coefficient representing the bias (which is a possible parallel dislocation of a given hyperplane). The analyzed FV were:
ARC (3 mm Zone): Anterior radius of curvature in the 3.0 mm zone centered on the thinnest location of the cornea; ARTmax: Ambrosio relational thickness maximum; ARTmin: Ambrosio relational thickness minimum; BAD D: Belin/Ambrosio enhanced ectasia total deviation value ;BAD Daa: Deviation of the ART average; BAD Dam: Deviation of the ART max; BAD Db: Deviation of back elevation difference map; BAD De: Deviation from the posterior elevation at the thinnest considering BFS 8 mm; BAD Df: Deviation of front elevation difference map; BAD Df: Deviation of minimum thickness; BAD Dk: Deviation from Kmax; BAD Dp: Deviation of average pachymetric progression;BAD Dr: Deviation from the more negative value on the relative thickness map; BAD Dy: Deviation from the vertical displacement of the thinnest point from the apex; C.Vol D 3mm: corneal volume of 3 mm diameter area; C.Vol D 5mm: corneal volume of 5 mm diameter area; C.Vol D 7mm: corneal volume of 7 mm diameter area; C.Vol D 10mm: corneal volume of 10 mm diameter area; D2 mm / Pachy Min: The quotient of D2 mm / Pachy Min; D2 mm: Average corneal thickness of 2 mm circle centered on the thinnest location; D4 mm / Pachy Min: The quotient of D4 mm / Pachy Min; D4 mm: Average corneal thickness of 4 mm circle centered on the thinnest location; D6 mm / Pachy Min: The quotient of D6mm / Pachy Min; D6 mm: Average corneal thickness of 6 mm circle centered on the thinnest location; D8 mm / Pachy Min: The quotient of D8 mm / Pachy Min; D8 mm: Average corneal thickness of 8 mm circle centered on the thinnest location; Ele B BFS 8 mm Max. 4 mm Zone: Elevation parameter derived from the back surface centered at the point with highest value within the 4 mm (diameter) using the 8 mm best-fit sphere; Ele B BFS 8mm Apex: Elevation parameter derived from the back surface centered at the apex calculated using the 8 mm best-fit sphere; Ele B BFS 8mm Thinnest: Elevation parameter derived from the back surface centered at the thinnest point using the 8 mm best-fit sphere; Ele B BFTE 8 mm Max. 4 mm Zone: Elevation parameter derived from the back surface centered at the point with highest value within the 4 mm (diameter) using the 8 mm best-fit toric ellipsoid; Ele B BFTE 8mm Apex: Elevation parameter derived from the back surface centered at the apex calculated using the 8 mm best-fit toric ellipsoid; Ele B BFTE 8mm Thinnest: Elevation parameter derived from the back surface centered at the thinnest point using the 8 mm best-fit toric ellipsoid; Ele F BFS 8 mm Max. 4 mm Zone: Elevation parameter derived from the front surface centered at the point with highest value within the 4 mm (diameter) using the 8 mm best-fit sphere; Ele F BFS 8mm Apex: Elevation parameter derived from the front surface centered at the apex calculated using the 8 mm best-fit sphere; Ele F BFS 8mm Thinnest: Elevation parameter derived from the front surface centered at the thinnest point using the 8 mm best-fit sphere; Ele F BFTE 8 mm Max. 4 mm Zone: Elevation parameter derived from the front surface centered at the point with highest value within the 4 mm (diameter) using the 8 mm best-fit toric ellipsoid; Ele F BFTE 8mm Apex: Elevation parameter derived from the front surface centered at the apex calculated using the 8 mm best-fit toric ellipsoid; Ele F BFTE 8mm Thinnest: Elevation parameter derived from the front surface centered at the thinnest point using the 8 mm best-fit toric ellipsoid; IHA: Index highest asymmetry; IHD: Index highest decentration; ISV: Index of surface variance; IVA: Index of vertical asymmetry; KI: Keratoconus index; Pachy Min: Corneal thickness at the thinnest point; Pachy Min Y: Position of minimum corneal thickness in relation of Y axis centered on cornea apex; PRC (3mm Zone): Posterior radius of curvature in the 3.0 mm zone centered on the thinnest location of the cornea; Rel Pachy Min: Relative corneal thickness at the thinnest point; RMS HOA (CB): root mean square of high order aberration of cornea back; RMS HOA (CF): root mean square of high order aberration of cornea front; RMS HOA (Cornea): root mean square of high order aberration of total cornea; RPIavg: Average pachymetric progression index; RPImax: Maximum pachymetric progression index; RPImin: Minimum pachymetric progression index; Z 3 -1 (CB): 3rd order vertical coma aberration cornea back; Z 3 -1 (CF): 3rd order vertical coma aberration of cornea front; Z 3 -1 (Cornea): 3rd order vertical coma aberration total cornea; Z 5 -1 (CB): 5th order vertical coma aberration of cornea back; Z 5 -1 (CF): 5th order vertical coma aberration of cornea front. All Zernike measurements were made for a corneal diameter of 6 mm.
Enrollment
Sex
Volunteers
Inclusion criteria
Patients were considered to be very asymmetric (VAE-NT) if the diagnosis of ectasia was confirmed in one eye based on the previously described criteria and the fellow eye had a normal front surface curvature (topometric) map. Objective criteria for considering normal topography was applied for defining the cases of VAE-NT, including objective front surface curvature metrics derived from Pentacam. Normal topography was rigorously considered based on objective criteria (27, 28) of a maximum curvature Kmax (Steepest Front Keratometry) <47.2 diopters, a paracentral inferior-superior (I-S value) asymmetry value at 6 mm (3-mm radii) < 1.45, and keratoconus percentage index (KISA%) score < 60 and (29). The cutoff point used to discriminate normal corneas and VAE-NT from KC corneas was the maximal posterior elevation (< 29 µm). This cutoff point had been determined in a previous study, using the same instrument and the same setting. The posterior elevation map was displayed with a 5-mm color-coded scale, and maximal posterior elevation was measured manually using the cursor in the central 5 mm.
Exclusion criteria
The following exclusion criteria were adopted: history of ocular trauma; chronic use of eye medication, glaucoma; dry eye syndrome; corneal scarring; neurotrophic keratopathy; severe meibomian gland dysfunction; vulnerable state owing to physical or mental illness and with language-related difficulties; pregnant or breastfeeding.
588 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal